Highest Risk of ALCL in ANZ is with Grade 4 Surface Breast Implants

In a first of its kind an ANZ study reveals the relative risk for local patients obtaining ALCL following breast implants and how the risk varies with implant type. Magnusson M, Beath K, Cooter R, Locke M, Prince HM, Elder E, Deva AK. The Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Australia and New Zealand Confirms the Highest Risk for Grade 4 Surface Breast Implants. Plast Reconstr Surg. 2019 May;143(5):1285-1292